ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,046 filers reported holding ASTRAZENECA PLC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,793 | -91.3% | 53 | -91.6% | 0.00% | -100.0% |
| Q1 2023 | $43,570 | +11.8% | 628 | +9.2% | 0.01% | 0.0% |
| Q4 2022 | $38,966 | +116.5% | 575 | +72.7% | 0.01% | +150.0% |
| Q3 2022 | $18,000 | -10.0% | 333 | +8.8% | 0.00% | 0.0% |
| Q2 2022 | $20,000 | -31.0% | 306 | -30.6% | 0.00% | -33.3% |
| Q1 2022 | $29,000 | +11.5% | 441 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $26,000 | -10.3% | 441 | -8.5% | 0.00% | -25.0% |
| Q3 2021 | $29,000 | -31.0% | 482 | -37.3% | 0.00% | +33.3% |
| Q2 2021 | $42,000 | +162.5% | 769 | +134.5% | 0.00% | +50.0% |
| Q1 2021 | $16,000 | -15.8% | 328 | -9.1% | 0.00% | -50.0% |
| Q2 2020 | $19,000 | +18.8% | 361 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $16,000 | -61.9% | 361 | -57.3% | 0.00% | -57.1% |
| Q4 2019 | $42,000 | +147.1% | 845 | +116.1% | 0.01% | +133.3% |
| Q3 2019 | $17,000 | +6.2% | 391 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $16,000 | – | 391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |